Zetia vs. Praluent

See how Zetia and Praluent compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Zetia is a once-daily oral pill that blocks cholesterol absorption in the gut, while Praluent is an injectable antibody that helps the liver clear more LDL cholesterol from the blood.

  • Praluent has dedicated trial data showing it reduces heart attacks, strokes, and related hospitalizations in people with existing cardiovascular disease, a benefit not established for Zetia alone.

  • Generic ezetimibe costs far less out of pocket than Praluent, which has no generic version and requires self-injection every two or four weeks.

Zetia vs. Praluent Drug Summary

Zetia

Zetia (ezetimibe) is a cholesterol absorption inhibitor that lowers LDL cholesterol by blocking its uptake in the small intestine. It's FDA-approved for primary hyperlipidemia, mixed hyperlipidemia, and familial hypercholesterolemia, often paired with a statin. It comes as a 10 mg tablet taken once a day, with or without food.

Praluent

Praluent (alirocumab) is a PCSK9 inhibitor, a lab-made antibody that helps the liver remove more LDL cholesterol from the blood. It's FDA-approved for primary hyperlipidemia, familial hypercholesterolemia, and lowering cardiovascular risk in people with existing heart disease. It's injected under the skin every two or four weeks using a prefilled pen.

Zetia vs. Praluent Side Effects

Zetia

Most common
upper respiratory tract infection (up to 4.3%)
diarrhea (up to 4.1%)
nasopharyngitis (with statin) (up to 3.7%)
arthralgia (up to 3.0%)

Praluent

Most common
nasopharyngitis (up to 11.3%)
injection site reactions (up to 7.2%)
influenza (up to 5.7%)
urinary tract infection (up to 4.8%)

Zetia vs. Praluent Dosage

Zetia

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 10 mg once daily Same as starting
Dose changes None Fixed dose

Praluent

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 75 mg every 2 weeks At the start
Maximum dose 300 mg every 4 weeks If needed
Dose changes 2 increases As tolerated

Zetia vs. Praluent Indications

Zetia

Zetia is used as an add-on to diet, alone or with a statin, to lower LDL cholesterol in adults with high cholesterol. It also treats mixed hyperlipidemia when combined with fenofibrate, and it treats familial hypercholesterolemia in adults and children age 10 and up when combined with a statin.

  • Primary hyperlipidemia, alone or with a statin

  • Mixed hyperlipidemia, with fenofibrate

  • Heterozygous familial hypercholesterolemia, ages 10+, with a statin

Praluent

Praluent is used as an add-on to a maximally tolerated statin to further lower LDL cholesterol in adults with primary hyperlipidemia. It also treats heterozygous familial hypercholesterolemia in patients 8 and older, and it reduces the risk of heart attack, stroke, and related hospitalization in adults with established heart disease.

  • Primary hyperlipidemia, add-on to statin therapy

  • Heterozygous familial hypercholesterolemia, ages 8+

  • Reducing cardiovascular risk in established heart disease

Zetia vs. Praluent Pros and Cons

Zetia

Zetia works through a different pathway than statins, which makes it a useful add-on when a statin alone isn't enough. It's taken as a simple daily pill rather than an injection, and generic versions have made it widely affordable.

Pros

  • Oral tablet, no injections needed

  • Generic available, roughly $8 to $50 a month before savings programs

  • Long track record since its 2002 approval

  • Can be paired with fenofibrate for mixed hyperlipidemia

Cons

  • Produces a more modest LDL reduction than PCSK9 inhibitors

  • Not approved as monotherapy for homozygous familial hypercholesterolemia

  • Risk of liver enzyme elevation and muscle problems, especially with a statin

  • Not established to lower cardiovascular events when used alone

Praluent

Praluent offers a distinct mechanism for patients who need more LDL lowering than statins and ezetimibe provide, and it's the only PCSK9 inhibitor with both every-2-week and monthly dosing options. It also has dedicated outcomes data showing cardiovascular risk reduction, though it costs substantially more and has no generic option.

Pros

  • Flexible dosing: every 2 weeks or once a month

  • Backed by ODYSSEY OUTCOMES trial for cardiovascular risk reduction

  • Approved for children with HeFH as young as age 8

  • Larger average LDL reduction than oral cholesterol drugs

Cons

  • Requires self-injection with a prefilled pen

  • Roughly $500 to $640 a month before savings programs, no generic available

  • Injection site reactions are common

  • Serious hypersensitivity reactions have been reported

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.